{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:52:00Z","timestamp":1790754720285,"version":"4.1.0"},"publisher-location":"Cham","reference-count":42,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030876487","type":"print"},{"value":"9783030876494","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-87649-4_9","type":"book-chapter","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T12:03:00Z","timestamp":1643803380000},"page":"175-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Moyamoya Disease-Standards and Advances in Revascularization Procedure and Peri-operative Management"],"prefix":"10.1007","author":[{"given":"Miki","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \u2018moyamoya\u2019 disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2176\/nmc.52.327","volume":"52","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Tominaga T. Lessons learned from moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo). 2012;52:327\u201332.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.236.45","volume":"236","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Tominaga T. Current status of revascularization surgery for moyamoya disease: special consideration for its \u2018internal carotid-external carotid (IC-EC) conversion\u2019 as the physiological reorganization system. Tohoku J Exp Med. 2015;236:45\u201353.","journal-title":"Tohoku J Exp Med"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (Spontaneous Occlusion of the Circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","volume":"45","author":"S Miyamoto","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45:1415\u201321.","journal-title":"Stroke"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/STROKEAHA.115.010819","volume":"47","author":"JC Takahashi","year":"2016","unstructured":"Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, et al. Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke. 2016;47:37\u201343.","journal-title":"Stroke"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2335\/scs.46.1","volume":"46","author":"T Tominaga","year":"2018","unstructured":"Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, et al. Recommendations for the management of moyamoya disease: A statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) [2nd edition]. Surg Cereb Stroke. 2018;46:136\u201340. (In Japanese)","journal-title":"Surg Cereb Stroke"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1161\/STROKEAHA.114.005624","volume":"45","author":"WS Cho","year":"2014","unstructured":"Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, et al. Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke. 2014;45:3025\u201331.","journal-title":"Stroke"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3171\/2016.11.JNS161650","volume":"128","author":"T Funaki","year":"2018","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg. 2018;128:777\u201384.","journal-title":"J Neurosurg"},{"issue":"2","key":"9_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3171\/2017.9.JNS17576","volume":"130","author":"T Funaki","year":"2019","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg. 2019;130(2):337\u2013673. https:\/\/doi.org\/10.3171\/2017.9.JNS17576.","journal-title":"J Neurosurg"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","volume":"128","author":"JP Jeon","year":"2018","unstructured":"Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg. 2018;128:793\u20139.","journal-title":"J Neurosurg"},{"key":"9_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002218","volume":"94","author":"C Qian","year":"2015","unstructured":"Qian C, Yu X, Li J, Chen J, Wang L, Chen G. The efficacy of surgical treatment for the secondary prevention of stroke in symptomatic moyamoya disease: a meta-analysis. Medicine (Baltimore). 2015;94:e2218.","journal-title":"Medicine (Baltimore)"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2176\/nmc.ra.2014-0305","volume":"55","author":"S Kuroda","year":"2015","unstructured":"Kuroda S, AMORE Study Group. Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurol Med Chir (Tokyo). 2015;55:194\u20138.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/2018.10.JNS181139","volume":"132","author":"T Funaki","year":"2019","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Fujimura M, Tomata Y, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg. 2019;132:408\u201314. https:\/\/doi.org\/10.3171\/2018.10.JNS181139.","journal-title":"J Neurosurg"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3171\/2017.11.JNS171990","volume":"130","author":"M Fujimura","year":"2019","unstructured":"Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, et al. Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg. 2019;130:1453\u20139. https:\/\/doi.org\/10.3171\/2017.11.JNS171990.","journal-title":"J Neurosurg"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/j.wneu.2018.08.132","volume":"120","author":"K Tokairin","year":"2018","unstructured":"Tokairin K, Kazumata K, Uchino H, Ito M, Ono K, Tatezawa R, et al. Post-operative intracerebral hemorrhage after combined revascularization surgery in moyamoya disease: profiles and clinical associations. World Neurosurg. 2018;120:e593\u2013600. https:\/\/doi.org\/10.1016\/j.wneu.2018.08.132.","journal-title":"World Neurosurg"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00381-007-0551-y","volume":"24","author":"M Fujimura","year":"2008","unstructured":"Fujimura M, Kaneta T, Tominaga T. Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease. Childs Nerv Syst. 2008;24:827\u201332.","journal-title":"Childs Nerv Syst"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10143-017-0845-9","volume":"40","author":"XC Tu","year":"2017","unstructured":"Tu XC, Fujimura M, Rashad S, Mugikura S, Sakata H, Niizuma K, et al. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the \u2018watershed shift\u2019. Neurosurg Rev. 2017;40:507\u201312.","journal-title":"Neurosurg Rev"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000500802","volume":"47","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, Fujimura M, Kameyama M, Mugikura S, Endo H, Takeuchi Y, et al. Incidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease. Cerebrovasc Dis. 2019;47:178\u201387.","journal-title":"Cerebrovasc Dis"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.4.PEDS09478","volume":"6","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya disease. Watershed shift and hyperperfusion. J Neurosurg Pediatr. 2010;6:73\u201381.","journal-title":"J Neurosurg Pediatr"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10143-009-0184-6","volume":"32","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Kaneta T, Shimizu H, Tominaga T. Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev. 2009;32:245\u20139.","journal-title":"Neurosurg Rev"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1227\/00006123-198408000-00006","volume":"15","author":"RC Heros","year":"1984","unstructured":"Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES. Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery. 1984;15:178\u201385.","journal-title":"Neurosurgery"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.wneu.2013.06.010","volume":"82","author":"GA Schubert","year":"2014","unstructured":"Schubert GA, Biermann P, Weiss C, Seiz M, Vajkoczy P, Schmiedek P, et al. Risk profile in extracranial\/intracranial bypass surgery\u2014the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures. World Neurosurg. 2014;82:672\u20137.","journal-title":"World Neurosurg"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","volume":"105","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Zhang Q, Zhang D, Zhao Y. The effect of aspirin in the postoperative management of adult ischemic moyamoya disease. World Neurosurg. 2017;105:728\u201331.","journal-title":"World Neurosurg"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after EC-IC bypass for moyamoya disease: comparative study with non-moyamoya patients using n-isopropyl-p-[(123)i]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68:957\u201365.","journal-title":"Neurosurgery"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67:273\u201382.","journal-title":"Surg Neurol"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1159\/000132205","volume":"25","author":"JE Kim","year":"2008","unstructured":"Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK. Transient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis. 2008;25:580\u20136.","journal-title":"Cerebrovasc Dis"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.surneu.2008.02.031","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71:442\u20137.","journal-title":"Surg Neurol"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.surneu.2007.07.077","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009;71:223\u20137.","journal-title":"Surg Neurol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/STROKEAHA.112.654723","volume":"43","author":"H Uchino","year":"2012","unstructured":"Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT\/positron emission tomography study. Stroke. 2012;43:2610\u20136.","journal-title":"Stroke"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000504835","volume":"48","author":"M Kameyama","year":"2019","unstructured":"Kameyama M, Fujimura M, Tashiro R, Sato K, Endo H, Niizuma K, et al. Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease: implication for the pathological threshold of local cerebral hyperperfusion. Cerebrovasc Dis. 2019;48:217\u201325.","journal-title":"Cerebrovasc Dis"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/bja\/aes470","volume":"110","author":"JW Hwang","year":"2013","unstructured":"Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, et al. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anesth. 2013;110:773\u20139.","journal-title":"Br J Anesth"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/NEU.0000000000000238","volume":"74","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. Minocycline prevents focal neurologic deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014;74:163\u201370.","journal-title":"Neurosurgery"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00701-014-2054-4","volume":"156","author":"N Horie","year":"2014","unstructured":"Horie N, Fukuda Y, Izumo T, Hayashi K, Suyama K, Nagata I. Indocyanine green videoangiography for assessment of postoperaive hyperperfusion in moyamoya disease. Acta Neurochir. 2014;156:919\u201326.","journal-title":"Acta Neurochir"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3171\/2009.4.JNS08585","volume":"111","author":"A Nakagawa","year":"2009","unstructured":"Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T. Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg. 2009;111:1158\u201364.","journal-title":"J Neurosurg"},{"key":"9_CR36","doi-asserted-by":"publisher","unstructured":"Katsuki M, Fujimura M, Tashiro R, Tomata Y, Nishizawa T, Tominaga T. Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients\u2014case-control study. Neurosurg Rev. 2021;44(4):2191\u2013200. https:\/\/doi.org\/10.1007\/s10143-020-01395-z.","DOI":"10.1007\/s10143-020-01395-z"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.","journal-title":"J Hum Genet"},{"key":"9_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022452","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Minoehary Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22452.","journal-title":"PLoS One"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.6.JNS201037","volume":"23","author":"R Tashiro","year":"2020","unstructured":"Tashiro R, Fujimura M, Katsuki M, Nishizawa T, Tomata Y, Niizuma K, et al. Prolonged\/delayed cerebral hyperperfusion in adult moyamoya disease patients with RNF213 gene polymorphism c.14576G>A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. J Neurosurg. 2020;23:1\u20138. https:\/\/doi.org\/10.3171\/2020.6.JNS201037. Online ahead of print","journal-title":"J Neurosurg"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000509740","volume":"49","author":"T Nishizawa","year":"2020","unstructured":"Nishizawa T, Fujimura M, Katsuki M, Mugikura S, Tashiro R, Sato K, et al. Prediction of cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis by three-dimensional-time-of-flight magnetic resonance angiography in adult patients with moyamoya disease. Cerebrovasc Dis. 2020;49:396\u2013403.","journal-title":"Cerebrovasc Dis"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis. 2012;33:436\u201345.","journal-title":"Cerebrovasc Dis"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","volume":"47","author":"H Uchino","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K. Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke. 2016;47:1930\u20132.","journal-title":"Stroke"}],"container-title":["Advances and Technical Standards in Neurosurgery","Cerebrovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-87649-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T12:14:49Z","timestamp":1651752889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-87649-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030876487","9783030876494"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-87649-4_9","relation":{},"ISSN":["0095-4829","1869-9189"],"issn-type":[{"value":"0095-4829","type":"print"},{"value":"1869-9189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by JSPS KAKENHI grant number 20K09362 (Miki Fujimura).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}